Sunshine Biopharma Inc. (SBFM) stock
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3099% below fair value
$2.70−0.14 (-4.93%)
Close on Nov 13, 2026Market cap $751.46KP/E –Yield –
Sunshine Biopharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Sunshine Biopharma's price to sales ratio was 0.2× on Nov 11, 2026, against 35.4× a year earlier. Over the last 5 years it ranged from 0.0× to 101.7×, with a median of 21.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −29.8 |
| 2025 | Dec 31, 2025 | 30.0× | −6.4 |
| 2024 | Dec 31, 2024 | 36.4× | +35.7 |
| 2023 | Dec 29, 2023 | 0.7× | −48.6 |
| 2022 | Dec 30, 2022 | 49.2× | +47.5 |
| 2021 | Dec 31, 2021 | 1.8× | +0.7 |
| 2020 | Dec 31, 2020 | 1.1× | +1.1 |
| 2019 | Aug 27, 2019 | 0.0× | −0.0 |
| 2018 | Jul 10, 2018 | 0.0× | −0.0 |
| 2016 | Jul 29, 2016 | 0.0× | +0.0 |
| 2015 | Dec 31, 2015 | 0.0× | – |
See a number that looks wrong?